Protalix BioTherapeutics, Inc. (PLX) Weighted Average Number of Shares Outstanding, Diluted 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2011 to 2024.
  • Protalix BioTherapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 73 M shares, a 27.1% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 82.4 M shares, a 70% increase from 2022.
  • Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 48.5 M shares, a 9.81% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 44.1 M shares, a 51.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 73 M +15.6 M +27.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 82.4 M +34 M +70% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 83.8 M +34.3 M +69.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 83.2 M +35.9 M +75.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 57.5 M +11.6 M +25.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 48.5 M +4.33 M +9.81% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 49.5 M +3.94 M +8.65% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 47.3 M +1.89 M +4.16% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 45.8 M +5.91 M +14.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 44.1 M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 45.6 M +12.7 M +38.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 45.4 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 39.9 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 32.9 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2018 147 M -46 M -23.9% Apr 1, 2018 Jun 30, 2018 10-Q/A 2019-03-18
Q2 2017 193 M +92.8 M +93.1% Apr 1, 2017 Jun 30, 2017 10-Q/A 2019-03-18
Q2 2016 99.8 M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q2 2013 92.3 M -2.58 M -2.72% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-08
Q2 2012 94.9 M +9.3 M +10.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q2 2011 85.6 M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.